Silk Road Medical’s Q2 Margins Hit By Manufacturing Expansion Costs
Silk Road Medical Inc (NASDAQ:SILK) posted Q2 revenue of $33.2 million, an increase of 25% Y/Y, driven primarily by increased…
Kraft Heinz Reports Q2 Earnings Above Street View
Kraft Heinz Co (NASDAQ:KHC) reported a second-quarter FY22 sales decline of 0.9% year-on-year to $6.55 billion, beating the consensus of…
Medicenna Announces New Clinical Data Providing Preliminary Evidence Of MDNA11’s Single Agent Anti-Cancer Activity In The Phase 1/2 ABILITY Study
-- Tumor control was achieved in four of ten evaluable patients with advanced solid tumors unresponsive to other treatments enrolled in the ABILITY Study’s low and mid-stage dose escalation cohorts
--
Mustang Bio Announces First Patient Successfully Treated By Ex Vivo Lentiviral Gene Therapy To Treat RAG1 Severe Combined Immunodeficiency
Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for
Bluejay Diagnostics Highlights PResentatin At AACC 2022
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness
Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical
Soligenix Receives Agreement From FDA On Initial Pediatric Study Plan For HyBryte For The Treatment Of Cutaneous T-Cell Lymphoma
Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced
Wyndham Hotels Q2 Earnings Top Estimates Helped By High Demand
Wyndham Hotels & Resorts Inc (NYSE:WH) reported a second-quarter FY22 sales decline of 4.9% year-on-year, to $386 million, beating the consensus…
Amid Legal Spat With Elon Musk, Twitter Sets Date For Shareholder Vote On Buyout Deal
Twitter Inc (NYSE: TWTR) has scheduled a shareholder vote on Tesla Inc (NASDAQ: TSLA) CEO Elon Musk’s proposed $44 billion takeover bid, from which the latter has walked away.
Recap Of Tuesday’s Biotech Catalysts – End of The Day Summary
European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg…
Putin, Russia Pulling Out Of International Space Station After 2024: Elon Musk Had This To Say About It
The largest country is Europe by land size announced plans to end its cooperation on one of the key pieces to space exploration and data collection Tuesday.